Sophiris Bio, Inc.
SPHS
SPHS was delisted on the 11th of March, 2020.
19 hedge funds and large institutions have $3.31M invested in Sophiris Bio, Inc. in 2016 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 10 closing their positions.
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
17% less capital invested
Capital invested by funds: $3.98M → $3.31M (-$673K)
17% less funds holding
Funds holding: 23 → 19 (-4)
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$217K |
| 2 |
AL
Airain Ltd
St. Peter Port,
Guernsey
|
+$44.2K |
| 3 |
Jane Street
New York
|
+$37.5K |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$28.8K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$28.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Boxer Capital
San Diego,
California
|
-$786K |
| 2 |
GCM
Gruss Capital Management
New York
|
-$775K |
| 3 |
Morgan Stanley
New York
|
-$276K |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$191K |
| 5 |
AIM
Alambic Investment Management
Belvedere,
California
|
-$35K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Walleye Trading
New York
| – | -$8K | -5,800 | Closed |
|
27
JP Morgan Chase
New York
| – | -$7K | -4,200 | Closed |
|
|
TRCT
28
Tower Research Capital (TRC)
New York
| – | -$2K | -1,395 | Closed |
|
29
Citigroup
New York
| – | -$1K | -1,000 | Closed |
|
SPHS Hedge Fund Activity: Q2 2016 in Review
19 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Sophiris Bio, Inc. (SPHS) for Q2 2016, worth a combined $3.31M — down 17% from $3.98M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of SPHS and 6 opened new positions — a net loss of 4 holders — while 5 trimmed existing stakes and 6 added.
The largest buyer was Vanguard Group, adding an estimated $217K. The largest seller was Boxer Capital, exiting entirely with an estimated $786K sold.
- 19 institutional investors held Sophiris Bio, Inc. (SPHS) as of Q2 2016, down from 23 in Q1 2016.
- Funds reported $3.31M of Sophiris Bio, Inc. stock for Q2 2016, down 17% quarter-over-quarter.
- 6 funds opened new Sophiris Bio, Inc. positions in Q2 2016 and 10 closed out, a net change of -4 holders.
- The largest Sophiris Bio, Inc. buyer in Q2 2016 was Vanguard Group, an estimated $217K added.
- The largest Sophiris Bio, Inc. seller in Q2 2016 was Boxer Capital, an estimated $786K sold.
Based on aggregated 13F filings for Q2 2016.